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Objective: Perioperative infection of an aortic graft is one of the most devastating complications of vascular surgery, with
a mortality rate of 10% to 30%. The rate of amputation of the lower limbs is generally >25%, depending on the graft
material, the location of the graft and infection, and the bacterial virulence. In vitro studies suggest that an antibiotic-
impregnated graft may help prevent perioperative graft infection. In a pilot animal study, we tested a locally developed
technique of bonding Dacron aortic grafts with three antimicrobial agents to evaluate the ensuing synergistic preventive
effect on direct perioperative bacterial contamination.
Methods: We surgically implanted a 6-mm vascular knitted Dacron graft in the infrarenal abdominal aorta of six Sinclair
miniature pigs. Two pigs received unbonded, uninoculated grafts; two received unbonded, inoculated grafts; and two
received inoculated grafts that were bonded with chlorhexidine, rifampin, and minocycline. Before implantation, the two
bonded grafts and the two unbonded grafts were immersed for 15 minutes in a 2-mL bacterial solution containing 1 to
2  107 colony-forming units (CFU)/mL of Staphylococcus aureus (ATCC 29213). Two weeks after graft implantation,
the pigs were euthanized, and the grafts were surgically excised for clinical, microbiologic, and histopathologic study.
Results: The two bonded grafts treated with S aureus showed no bacterial growth upon explant, whereas the two
unbonded grafts treated with S aureus had high bacterial counts (6.25  106 and 1.38  107 CFU/graft). The two
control grafts (unbonded and untreated) showed bacterial growth (1.8  103 and 7.27  103 CFU/graft) that
presumably reflected direct, accidental perioperative bacterial contamination; S cohnii ssp urealyticus and S chromogenes,
but not S aureus, were isolated. The histopathologic and clinical data confirmed themicrobiologic findings. Only pigs that
received unbonded grafts showed histopathologic evidence of a perigraft abscess.
Conclusions: Our results suggest that bonding aortic grafts with this triple antimicrobial combination is a promising
method of reducing graft infection resulting from direct postoperative bacterial contamination for at least 2 weeks.
Further studies are needed to explore the ability of this novel graft to combat one of the most feared complications in
vascular surgery. (J Vasc Surg 2012;56:794-801.)
Clinical Relevance: This study introduces a novel bonded Dacron aortic graft for the prevention of perioperative aortic
graft infection. The quantitative results of our experimental studies showed that the bonding of three antimicrobial
agents (rifampin, minocycline, and chlorhexidine) to aortic grafts nearly prevented aortic graft infection by synergistically
prolonging antistaphylococcal activity. Use of an antibiotic-bonded prosthetic graft with antistaphylococcal activity
should be considered in patients who have arterial infections caused by Staphylococcus aureus. After the preventive effect
of this graft and its safety have been further assessed, its use may be recommended for the in situ replacement of infected
grafts and possibly for routine primary cases, especially in immunocompromised patients, patients with hostile abdomen,
and patients undergoing redo procedures.
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0Infection of an aortic graft is a devastating perioper-
ative complication of arterial surgery. Although the inci-
dence of graft infection is low (0.2%-5%), particularly in
the descending thoracic/thoracoabdominal aorta (0.5%-
1.9%), urgent attention is often required.1 Despite im-
provements in preventive measures, including atraumatic
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Volume 56, Number 3 Aboshady et al 795The most common pathogenic organism to cause early
(4 months) graft infections is Staphylococcus aureus
(32%), whereas S epidermidis causes most late (4 months)
vascular graft infections.1 Recently, the incidence of vascu-
lar infections with methicillin-resistant S aureus (MRSA)
has increased considerably (2%), especially in residents of
long-term facilities (23%-49%). MRSA infections are more
invasive and are accompanied by septicemia.4
Antibiotic-impregnated grafts may be useful in pre-
venting and decreasing the severity of vascular infections.
Rifampin is reportedly effective because it has a high affinity
for collagen- and gelatin-coated grafts, resulting in stable
bonding.5 In clinical studies, rifampin-bonded grafts have
shown promising results against microorganisms of low
virulence, such as S epidermidis, but have been less effective
against virulent bacteria, including MRSA.6-9
Our group has shown that the impregnation of central
venous catheters (CVCs) with minocycline and rifampin is
efficacious and safe in reducing catheter-related blood-
stream infections in cancer patients and in patients who are
critically ill.10-12 Moreover, our recent studies have shown
that CVCs impregnated with a triple combination of
chlorhexidine, rifampin, and minocycline (M/RCHX) en-
hance activity against MRSA and broaden the anti-biofilm
and antiadherence activities to include Pseudomonas
aeruginosa and Candida organisms.13,14 In the current
study, we examined the benefits of simultaneously bonding
M/RCHX to aortic grafts to assess the consequential effect on
reducing the risk of perioperative aortic graft infection by
direct operative bacterial contamination in an animal model.
METHODS
These animal studies were performed according to the
guidelines set by the Animal Welfare Committee at The
University of Texas Health Science Center, Houston,
Texas.
Animal model. The study comprised six Sinclair (Sin-
clair Bio Resources, Columbia, Mo) miniature pigs
(weight, 30-35 kg) that were divided into three groups
(Table I). Two pigs received unbonded, uninoculated
grafts (group A; controls); two pigs received unbonded,
inoculated grafts (group B); and two pigs received inocu-
lated grafts bonded with M/RCHX (group C). Before
Table I. Microbiologic findings of cultured aortic grafts
Group/pig Graft
A
Pig 1 Unbonded, uninoculated
Pig 2 Unbonded, uninoculated
B
Pig 3 Unbonded, inoculated
Pig 4 Unbonded, inoculated
C
Pig 5 Bonded, inoculated
Pig 6 Bonded, inoculated
CFU, Colony-forming units.implantation, groups B and C pigs received grafts that were 4mmersed for 15 minutes in 2-mL bacterial solution con-
aining 1 to 2 107 colony-forming units (CFU)/mL of S
ureus (ATCC 29213).
The pigs did not receive preoperative or postoperative
ntibiotics or blood transfusions. Ketoprofen and mor-
hine were administered for postoperative analgesia. The
igs were placed in individual cages, examined daily, and
onitored for symptoms of systemic toxicity, which could
e caused by the graft or the antimicrobials. The pigs were
uthanized 2 weeks after graft implantation, and the grafts
ere surgically excised for study.
Surgical protocol. Animals were anesthetized initially
y an intramuscular injection of a 1-mL mixture of zo-
amine (5 mg/mL), butorphanol (1 mg/mL), ketamine
10 mg/mL), and xylazine (2 mg/mL), followed by iso-
urane (0.5%-3%) throughout the operation. For analgesia,
e used 0.25% bupivacaine (1 mL/kg) before the inci-
ion and buprenorphine (0.01-0.02 mg/kg, subcutane-
usly or intramuscularly) postoperatively. A fentanyl trans-
ermal patch (75-100 g/kg/h) was placed immediately
fter surgery.
Strict aseptic conditions and techniques were used for
ll procedures, including the use of sterile protective cov-
ring, instruments, and drapes. The abdomen and left flank
ere clipped and surgically prepared. The infrarenal aorta
nd its bifurcation were exposed through a retroperitoneal
ncision. The infrarenal aorta was carefully dissected from
he surrounding tissues by sharp, blunt dissection of the
eriaortic tissues. The lumbar arterial branches were spared
o avoid spinal cord ischemia. Heparin (100-300 U/kg)
as administered intravenously, and the pigs were main-
ained on heparin (100-200 U/kg every 45 minutes) dur-
ng the operation.
The abdominal aorta was clamped with atraumatic
ascular clamps, and a 2.0-  1.0-cm Dacron roof patch
as sutured to a 2.0-cm aortotomy with 5-0 double-ended
olypropylene vascular suture to create a roof-patch angio-
lasty in a standard fashion. The total anastomotic time was
20 minutes per pig. The vascular clamps were released,
nd the suture line was observed for leakage. The wound
as irrigated with sterile saline, the retractors were re-
oved, and the wound was closed in layers in the usual
ashion. The skin was closed with subcuticular sutures of
CFU/graft Organism cultured
1.8  103 Staphylococcus cohnii ssp urealyticus
7.27  103 Staphylococcus chromogenes
6.25  106 Staphylococcus aureus
1.38  107 Staphylococcus aureus
0 None
0 None-0 Vicryl (Monosof, Syneture, Norwalk, Conn) to help
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September 2012796 Aboshady et alprevent infection. The surface of the closed incision and the
entire surgical area were cleaned and sprayed with 2%
chlorhexidine.
The pigs were allowed to recover from anesthesia before
they were returned to their cages. Antiplatelet therapy (10
mg/kg) was administered daily for 1 week after surgery.
Graft preparation. Dacron vascular grafts (Terumo
Cardiovascular Systems Corp, Ann Arbor, Mich) were im-
pregnated with M/RCHX by using a modified proprietary
method.15 This solvent-based impregnation method in-
volves precoating the grafts with a chlorhexidine solution
and then soaking them in a solvent solution of minocycline
and rifampin. The doses of rifampin (30 mg/mL) and
minocycline (15 mg/mL) were selected to ensure that the
largest graft would contain less than the normal daily dose
of both drugs used clinically. Uncoated grafts were used as
controls to show the ability of the bacterial challenge to
establish infection.
Bacterial challenge preparation. To examine the ef-
ficacy of the M/RCHX vascular grafts, impregnated (group
C) and uncoated grafts (group B) were inoculated with S
aureus (ATCC strain 29213). Fresh challenge bacteria were
streaked for isolation from frozen stock onto trypticase soy
agar and 5% sheep’s blood and incubated overnight. A
uniform colony was inoculated into Muller Hinton II broth
(25 mL) and incubated overnight at 37°C. The resulting
inoculum was diluted to a 0.5 McFarland standard and
further diluted in saline to a concentration of 1  106
CFU/mL for use in the bacterial challenge. Antibiotic-
coated and uncoated grafts were soaked in 25 mL of the S
aureus inoculum for 20 minutes before surgical implanta-
tion.
Graft excision. Pigs were given a lethal dose of
Beuthanasia (0.22 mL/kg; Merck, Summit, NJ) at the time
of euthanasia. The same sterile technique that was used for
graft implantation was used to reopen the retroperitoneal
incision. The grafts and attached segments of aortic wall
were excised for microbiologic and histopathologic studies.
Microbiologic assays. Samples of vascular tissue sur-
rounding the graft were homogenized for 2 minutes in
0.9% sterile saline (5 mL) by using a Stomacher Lab
Blender (Tekmar Corp, Cincinnati, Ohio). The resulting
homogenate was quantitatively cultured to determine the
efficacy of the antimicrobial grafts. All samples were cul-
tured in triplicate on trypticase soy agar with 5% sheep’s
blood following the Clinical and Laboratory Standards
Institute (formerly, National Committee for Clinical Lab-
oratory Standards) procedures. Microbes grown from the
homogenate were identified by using the API Staph Iden-
tification kit (bioMérieux, Marcy l’Etoile, France). Samples
identified as S aureus were further typed genetically as
described below for molecular comparison. Samples from
other areas with signs of infection (abscesses) were cultured
and typed for comparison with the inoculated strain.
Genetic strain typing from collected S aureus
isolates. Isolates identified as S aureus that were recovered
from inoculated pigs were genetically typed by using repet-
itive sequence-based polymerase chain reaction (rep-PCR) by using the DiversiLab rep-PCR strain typing system
bioMérieux), according to the manufacturer’s instruc-
ions. Strains were compared with the inoculated strain
ATCC 29213) to determine whether the recovered S
ureus isolates were the same as the inoculated ATCC
train.
Histopathologic studies. Samples from the site
here the graft was attached to the aorta (range, 1-2.5 cm)
ere sliced every 3 to 4 mm and were formalin-fixed and
araffin-embedded. Sections (5-m thick) were stained
ith hematoxylin and eosin, Movat pentachrome, and
ram stain. Histopathologic and microbiologic examina-
ions were performed by using Olympus MicroSuite soft-
are connected to an Olympus BX61 microscope (Olym-
us America, Melville, NY). For each 5-m section of the
araffin-embedded specimens, histopathologic sections
ere examined for signs of inflammation in two different
ow-power (original magnification,4) fields of the vascu-
ar wall.
Statistical analysis. The number of positive culture-
nfected grafts observed in the three groups of pigs was
ompared by using the t-test. A value of P  .05 was
onsidered statistically significant.
ESULTS
The six pigs survived the surgery and completed the
rotocol. For at least 7 days after graft implantation, all pigs
howed reduced food intake and altered behavior. Signs of
ostoperative infection (eg, fever, malaise, increased total
eukocyte count) were seen in the group B pigs (unbonded,
noculated grafts; Table II). One pig in group C (bonded,
noculated grafts) also showed clinical signs of infection due
o the formation of a deep wound abscess. Body tempera-
ures were elevated in group B pigs for 1 week after graft
mplantation but not in group A or group C pigs (Table II).
he pigs that received bacterial inoculations showed mod-
rate leukocytosis with low serum albumin levels for 2
eeks after graft implantation. Operative signs of infection
ere seen on the excised grafts of group B pigs, such as
erigraft exudates, abscess, and necrotic tissue, which were
ot seen in the other pigs.
Microbiologic assays were performed on matched
pecimens of aortic tissue samples surrounding the aortic
rafts. Quantification of the culture results showed sig-
ificantly lower bacterial counts for tissues from group A
control) pigs (1.8  103 and 7.27  103 CFU/graft)
han for specimens from group B (S aureus–treated,
nbonded grafts) pigs (6.25  106 and 1.38  107
FU/graft; P  .001; Table I). Specimens obtained
rom group C (S aureus–treated, bonded grafts) pigs
howed no bacterial growth. The organisms isolated from
he grafts of group A (control) pigs were S cohnii ssp
realyticus and S chromogenes, but not S aureus, indicating
hat the bacterial growth had resulted from direct acciden-
al perioperative bacterial contamination of the unbonded,
ninoculated grafts. Thus, the synergistic effect of the
onded graft in group C pigs may have prevented direct
acterial contamination with non-S aureus bacteria.
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Volume 56, Number 3 Aboshady et al 797Aortic graft specimens from both group B pigs were
infected with the same S aureus strain that was inoculated
onto the uncoated graft. For group C pigs, no staphylo-
cocci were recovered from the culture of the M/RCHX-
coated Dacron grafts inoculated with S aureus or from the
surrounding tissues. However, S aureus cultured from a
deep subcutaneous wound abscess of pig 5 in group C was
the same strain as the inoculated strain. The dendrogram
and virtual banding patterns in Fig 1 show that all S aureus
isolates recovered from the inoculated pigs are the same
strain used in the initial inoculum.
Results from the histopathologic analysis were concor-
Table II. Postoperative clinical and laboratory data after g
Variable
Group A
Pig 1 Pig 2 Pig
Fever, °C No No Yes (38
Heart rate, beats/min 108 126 99
SPO2, mm Hg N N 99
PCO2, mm Hg 24 13 27
TLC 9 (PNL) 8.4 (PNL) 14.5 (PN
Hematocrit 2 N N
Hemoglobin N 2 N
Platelet count 2 N N
Cholesterol N N Hig
ALT 2 1 1
ALP 2 2 2
Glucose 2 2 2
Albumin N N N
Total protein 2 N N
ALP, Alkaline phosphatase; ALT, alanine aminotransferase; Eo, eosinophils; L
PNL, neutrophils; SPO2, saturation of peripheral oxygen; TLC, total leukoc
Fig 1. The dendrogram and virtual banding patterns
(rep-PCR) showed that the inoculated Staphylococcus aur
was the same as the strain in the initial inoculum.dant with the microbiologic findings. Table III summarizes she main histopathologic outcomes for all samples. For all
hree groups, microscopic examination of aortic specimens
djacent to the graft implant showed marked adventitial
hickening, consisting predominantly of fibrosis and
hronic inflammation. Multinucleated giant cells were also
resent in all samples, often associated with the presence of
inute graft remnants. Specimens from the medial layer of
ll groups displayed sites, at irregular intervals, of mild-to-
oderate disruption of the lamellar structure, consisting
ostly of smooth muscle cell loss and increased matrix
eposition. This finding appeared to be related to the
lacement of sutures. The intimal layer was absent from all
mplantation in the abdominal aorta
Group B Group C
Pig 4 Pig 5 Pig 6
Yes (38.3) No No
115 92 78
94 96 93
20 23 36
) 13.9 (PNL, Ly, Eo) 8 (PNL, Ly) 6.25 (PNL, Ly)
2 N 2
N N N
2 N N
High High High
1 N N
2 2 2
2 2 2
1 1 N
2 2 2
phocytes; N, within normal range; PCO2, partial pressure of carbon dioxide;
unt.
repetitive sequence-based polymerase chain reaction
A) strain (ATCC 29213) recovered from the specimensraft i
3
.9)
L, Ly
hafter
eus (Samples at the site of graft implantation.
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September 2012798 Aboshady et alImportant differences were observed among the three
groups, mostly in the inflammatory infiltrate in the aortic
wall at the site of graft implantation (Table III). Specimens
from group A and group C predominantly showed chronic
inflammatory cell infiltrates (macrophages and lympho-
cytes). Gram stain yielded negative results in these two
groups, except for pig 4 in group A, which showed a few
gram-positive cocci near the graft implantation site (Fig 2),
with minimal to mild neutrophilic infiltration. In contrast,
specimens from pigs that received unbonded grafts with
bacterial inoculations (group B) showed abundant neutro-
philic infiltration with perigraft abscess formation (Figs 2-4
and Table III). In this same group, Gram stain revealed the
presence of gram-positive cocci in the aortic wall, near the
graft (Figs 2 and 3). In the specimen from pig 4, these
gram-positive cocci were quite numerous and arranged in
multiple clusters (Fig 3).
At the time of euthanasia, an anterior abdominal ab-
scess was observed in pig 4 in group B pig and in pig 5 in
group C, confirming that the inoculum was pathogenic.
DISCUSSION
Periprosthetic arterial graft infection is a rare but dev-
astating complication of arterial reconstructive surgery,
with a high incidence of mortality and limb loss.1 Few
clinical studies have described the results of managing
prosthetic graft infection after descending thoracic/thora-
coabdominal aortic aneurysmectomy.16-18 Nevertheless, in
most series, operative mortality has been 15% to 30%, and
limb loss has been30%. Hence, it is extremely desirable to
use every conceivable strategy to minimize or prevent bac-
terial seeding and subsequent graft infection.
In this study, we have introduced a novel bonded
aortic graft impregnated with three antimicrobial agents—
chlorhexidine, rifampin, and minocycline—and have exam-
ined its ability to prevent and reduce perioperative aortic
graft infections with the most common causative organism,
S aureus. Our results showed that the synergistic effect of
this antimicrobial combination helps reduce and prevent
direct perioperative bacterial contamination.
We used Sinclair miniature pigs in this study because
Table III. Comparison of histologic outcomes of perigraf
Group A
Pig 1 Pig 2 P
Media Focal fibrosis Focal fibrosis Focal fib
Adventitia thickening Yes Yes Yes
Inflammation Chronic Chronic Mixed (a
Abscess No No Yes
Neutrophils   
Macrophages   
Lymphocytes   
MNG   
Gram stain ?/negative Gram  cocci Gram 
?, Questionable; MNG, multinucleated giant cells.this strain is free of many common infectious diseases and is aften used in cardiovascular research, especially in studies of
ortic disease.19 Although dog models have been used to
tudy perioperative graft infections,20,21 using large ani-
als is costly and time-consuming because general anesthe-
ia with tracheal intubation and large experimental facilities
re required.22 To minimize these expenses, we implanted
he grafts in the abdominal aorta rather than in the thoracic
tic tissues
Group B Group C
Pig 4 Pig 5 Pig 6
Focal fibrosis Focal fibrosis Focal fibrosis
Yes Yes Yes
foci) Mixed (acute foci) Chronic Chronic
Yes No No
  
  
  
  
i Abundant Gram  cocci Negative Negative
ig 2. Representative images of aortic specimens and adjacent
raft material stained with (I) hematoxylin and eosin, (II) Movat
entachrome, and Gram stain. A and B, Images from pig 2 (group
) show a small cluster of gram-positive cocci and mild neutro-
hilic infiltration near the graft implantation site. C and D, Images
rom pig 4 (group B) show multiple clusters of gram-positive cocci
arrows) and abscess formation (asterisk). E and F, Images from
ig 6 (group C) show negative Gram staining. Bar 200 m in B
nd F and 1 mm in D.t aor
ig 3
rosis
cute
coccorta and used roof-patch angioplasty rather than a tube-
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Volume 56, Number 3 Aboshady et al 799graft replacement to simplify the technique and reduce
operative and postoperative morbidities.
Our group has previously evaluated the efficacy of
long-term, nontunneled silicone CVCs impregnated with
minocycline and rifampin (M-R) in reducing catheter-
related bloodstream infections in cancer patients.23 In this
prospective, randomized, double-blind trial, 17 catheter-
related infections were detected in the bloodstream of 174
patients with a malignancy. Three of the 17 infections were
associated with the use of M-R catheters, and 14 were
Fig 3. High-power magnification image (bar  20 m) shows
dense clusters of gram-positive cocci in the perigraft tissue of pig 4
(group B).
Fig 4. Images of abscess formation in specimens from group B
pigs. Low-power magnification of aortic specimens are shown
from (A) pig 3 and (B) pig 4. Corresponding high-power magni-
fication images of aortic specimens are shown from (C) pig 3 and
(D) pig 4.C, Neutrophilic infiltration is seen surrounding a core of
graft and gram-positive bacterial remnants (br). D, An accumula-
tion of mostly dead neutrophils, fibrin, and loose connective tissue
is shown. A large cluster of gram-positive cocci is seen in the upper
left corner (bc). Bar  2 mm in A and 100 m in C.associated with the nonimpregnated CVCs; the rate of batheter-related bloodstream infection was 0.25 and 1.28/
000 catheter-days, respectively (P  .003). The etiologic
gent for most infections was gram-positive cocci. No
llergic reactions were associated with the M-R catheters.
lso, in prospective, randomized clinical studies and meta-
nalyses, CVCs impregnated with M-R were safe and re-
uced catheter-related bloodstream infections in cancer
atients and in critically ill patients.13,14,24-26 Because of
hese encouraging results, we assessed the synergistic effect of
/RCHX in reducing perioperative infections associated
ith aortic graft implantation, especially given that the
rimary etiologic agent is the same in both situations, and
ecent data have shown that the addition of chlorhexidine
o M-R enhances antimicrobial activity against resistant
acteria and fungi.13,14
We recently showed that CVCs and peripherally
nserted central catheters impregnated with M/RCHX
ompletely inhibited biofilm colonization of MRSA,
ancomycin-resistant Enterococcus faecium, P aerugi-
osa, and Candida spp in a manner superior to that of
atheters treated with M-R and chlorhexidine (P 
003).27 Furthermore, M/RCHX–coated CVCs had sig-
ificantly more effective and prolonged antimicrobial
ctivity for up to 3 weeks against MRSA and P aeruginosa
han uncoated CVCs or those coated with M-R or chlo-
hexidine/silver sulfadiazine (P  .0001). No side ef-
ects were reported.27
Although rifampin is well known to have excellent
actericidal activity against MRSA,28 its use as a single
gent could result in the rapid development of resistance to
his antibiotic. Rifampin has been widely used as part of a
riple combination of antimicrobial agents, in which each
gent works by a different mechanism of action to reduce
he potential for developing resistance. The M-R combina-
ion has been used to successfully treat various infections,
ncluding staphylococcal infections.29 Moreover, infection-
esistant grafts have been effective in combating perioper-
tive infections of aortic grafts.30 In studies involving a
uorum-sensing inhibitor or a sustained-release vancomy-
in sheet placed on a graft, communication between bacte-
ial cells was prevented.31
Infection-resistant vascular grafts have considerable ap-
eal. However, several important issues must be considered
hen antibiotic-loaded grafts are designed. It is essential
hat the bonding or sterilization process does not alter the
hemical nature of the drugs or the substrate used as a
arrier. Grafts containing silver and collagen are used more
requently in Europe20,32 but are less resistant to bactere-
ic infection with S aureus than most other pathogens that
ause early perioperative graft infections.21 The use of silver
ompounds bonded to the sewing ring of prosthetic heart
alves has been shown to significantly impair the ingrowth
f tissue into the fabric and is therefore thought to predis-
ose to subsequent valve dehiscence.33
Many groups have used minocycline to treat vascular
raft infections because of the increased prevalence of S
ureus infections; however, its use has been questioned
ecause of the development of resistant S aureus
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September 2012800 Aboshady et alstrains.34,35 This issue is especially important in patients
who undergo repeat arterial-grafting procedures after
problems with healing of the implant site or who have
medical conditions, such as diabetes or immunosuppres-
sion, that increase the risk of infection, including MRSA
infection. In patients considered at higher risk for pros-
thetic implant infection, empiric use of an antibiotic-
bonded vascular graft may be beneficial. Rifampin-soaked
polyester grafts have been used successfully as in situ re-
placement grafts in clinical and experimental models of
vascular graft infection caused by Staphylococcus spp, espe-
cially S epidermidis and S aureus.20 However, the antibiotic
is promptly leached out—within minutes or hours—
because the arterial blood rapidly leaches out the surface
adherent chemical, hence the need for long-term stable
bonding of the antibiotic within the graft fabric.
Our study focused on early or perioperative graft infec-
tions. About 53% of infections occur within the first 30
days, and 70% occur in the first 60 days.36,37 Preventing
perioperative infection of an aortic graft is obviously pref-
erable to surgical treatment of an infected graft, especially
in the case of late infections. An effective approach to
preventing early graft infection is to provide antibiotic
coverage during the early postoperative period that is
strong enough to last through this crucial, vulnerable pe-
riod. Our previous studies10,38 indicated that the M-R
combination remains active for 6 weeks, which can be
extended by adding chlorhexidine.13 Also, the doses used
in this study appear to be sufficient, because no growth of
bacteria was detected in pigs treated with bonded grafts. In
a study in dogs, Koshiko et al39 showed that rifampin-
gelatin grafts (implanted after soaking the graft in a
1-mg/mL rifampin solution) were not efficacious against
virulent organisms such as S aureus; however, these re-
searchers used a higher organism concentration (1  108
CFU/mL) than we did (2 mL of a bacterial solution
containing 1 to 2 107 CFU/mL). One of the advantages
of locally delivering antibiotics is the slow, continuous
release of antibiotics from the graft. Among the different
bonding techniques available, a glue has been used that
allows antibiotic release over the duration of 1 to 2 months;
however, the glue poses issues such as tissue toxicity and the
lack of resorption by the body.40
The limitations of our study include a small sample size
of six pigs; however, this was a pilot study, and additional
experiments are in progress. In addition, our study focused
on early graft infection rather than late graft infection; this
was partly because the graft infection occurs early in 53% to
70% of infections.36,37 Future studies will assess the ability
of our graft to prevent late graft infection with a follow-up
period of 2 weeks.
Finally, the animals in our study did not receive preop-
erative antibiotics. This was done so that we could subject
our hypothesis to the maximum testing challenge. Al-
though perioperative antibiotics are widely used and may
reduce the number and severity of graft infections, they do
not provide complete protection from early graft infec-
tions.41ONCLUSIONS
Our results suggest that bonding of aortic grafts with
hree antimicrobial agents—chlorhexidine, minocycline,
nd rifampin—is a promising method of reducing direct
ostoperative bacterial contamination for at least 2 weeks.
urther studies are needed to explore the ability of this
ovel graft to combat one of the most formidable compli-
ations in vascular surgery.
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